Association of pigment epithelium derived factor expression with cancer progression and prognosis: a meta-analysis study
- PMID: 35201465
- PMCID: PMC8777498
- DOI: 10.1007/s12672-021-00457-y
Association of pigment epithelium derived factor expression with cancer progression and prognosis: a meta-analysis study
Abstract
Background: Pigment epithelium derived factor (PEDF) is a secreted protein that strongly suppresses angiogenesis and directly inhibits cancer cells proliferation. The differential expression of PEDF has been observed in multiple types of human tumors. However, it is unclear as to how PEDF expression is associated with cancer progression and if PEDF could serve as a prognostic marker for cancer patients.
Methods: We performed a comprehensive search for the studies on PEDF expression in 14 top-ranked types of solid tumor cancer with the highest incidence. A systemic approach was used to screen for qualified studies and to extract data. Meta-analysis was performed to investigate if PEDF expression is associated with the TNM staging, tumor size, lymph node invasion, distal metastasis and pathological grade of tumor in a pan-cancer manner. A Kaplan-Meier curve was plotted with the digitally-reconstituted patient survival data to study the effect of PEDF expression on the prognosis of cancer patients.
Results: A total of nine studies were selected, reviewed and analyzed. Meta-analysis suggested that decreased PEDF protein expression was associated with higher TNM staging (OR = 2.13, 95% CI: 1.61-2.81), larger tumor size (OR = 1.42, 95% CI: 1.1-1.84), larger possibility of lymph node invasion (OR = 1.68, 95% CI: 1.26-2.22) and higher pathological grade (OR = 1.6, 95% CI: 1.2-2.13). No correlation was found between PEDF expression and tumor distal metastasis, gender or age. In addition, low PEDF protein level in tumor tissue is correlated with shorter overall survival (P < 0.05).
Conclusions: Low PEDF protein expression in cancer is significantly associated with more advanced cancer progression and significantly poorer survival. The differential clinical outcome among patients with various PEDF expression suggests its prognostic value.
Keywords: Cancer progression; Meta-analysis; Overall survival; Pigment epithelium derived factor (PEDF); Prognosis.
© 2021. The Author(s).
Conflict of interest statement
The authors declare that they have no conflicts of interest to declare that are relevant to the content of this article.
Figures






Similar articles
-
Inhibitory effects of pigment epithelium-derived factor on epithelial-mesenchymal transition, migration and invasion of breast cancer.Int J Clin Exp Pathol. 2017 Oct 1;10(10):10593-10602. eCollection 2017. Int J Clin Exp Pathol. 2017. PMID: 31966401 Free PMC article.
-
Expression of pigment epithelium-derived factor is associated with a good prognosis and is correlated with epithelial-mesenchymal transition-related genes in infiltrating ductal breast carcinoma.Oncol Lett. 2016 Jan;11(1):116-124. doi: 10.3892/ol.2015.3880. Epub 2015 Nov 6. Oncol Lett. 2016. PMID: 26870178 Free PMC article.
-
Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.Int J Mol Med. 2006 May;17(5):937-44. Int J Mol Med. 2006. PMID: 16596284
-
Therapeutic Potential of Pigment Epithelium-derived Factor in Cancer.Curr Pharm Des. 2019;25(3):313-324. doi: 10.2174/1381612825666190319112106. Curr Pharm Des. 2019. PMID: 30892156 Review.
-
Pigment Epithelium-Derived Factor and Sex Hormone-Responsive Cancers.Cancers (Basel). 2020 Nov 23;12(11):3483. doi: 10.3390/cancers12113483. Cancers (Basel). 2020. PMID: 33238558 Free PMC article. Review.
Cited by
-
Expression and significance of pigment epithelium-derived factor and vascular endothelial growth factor in colorectal adenoma and cancer.World J Gastrointest Oncol. 2024 Mar 15;16(3):670-686. doi: 10.4251/wjgo.v16.i3.670. World J Gastrointest Oncol. 2024. PMID: 38577437 Free PMC article.
-
Diagnostic, Therapeutic and Prognostic Potential of Pigment Epithelium-Derived Factor in Cancer.Int J Mol Sci. 2025 Jun 23;26(13):6004. doi: 10.3390/ijms26136004. Int J Mol Sci. 2025. PMID: 40649783 Free PMC article. Review.
-
Pigment Epithelial-Derived Factor in Pancreatic and Liver Cancers-From Inflammation to Cancer.Biomedicines. 2024 Oct 4;12(10):2260. doi: 10.3390/biomedicines12102260. Biomedicines. 2024. PMID: 39457573 Free PMC article. Review.
-
The Various Roles of PEDF in Cancer.Cancers (Basel). 2024 Jan 24;16(3):510. doi: 10.3390/cancers16030510. Cancers (Basel). 2024. PMID: 38339261 Free PMC article. Review.
References
-
- Tombran-Tink J, Johnson LV. Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells. Invest Ophthalmol Vis Sci. 1989;30(8):1700–1707. - PubMed
-
- Becerra SP, Palmer I, Kumar A, Steele F, Shiloach J, Notario V, Chader GJ. Overexpression of fetal human pigment epithelium-derived factor in Escherichia coli. A functionally active neurotrophic factor. J Biol Chem. 1993;268(31):23148–23156. - PubMed
-
- Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407(6801):249–257. - PubMed
-
- Folkman J, Bach M, Rowe JW, Davidoff F, Lambert P, Hirsch C, Goldberg A, Hiatt HH, Glass J, Henshaw E. Tumor angiogenesis—therapeutic implications. New Engl J Med. 1971;285(21):1182–2000. - PubMed
-
- Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science. 1999;285(5425):245–248. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous